To confirm these hypotheses, the results of immunohistological staining of DNA-PKcs in human cytological specimens or tumor tissue samples must be correlated with radiation therapy outcomes in patients with diagnosed thyroid cancers; this provides a simple method for predicting the radiosensitivity of thyroid tumor cells. This evidence concerns the gene PRKDC and thyroid cancer.